A Single Center Retrospective Chart Review of Monitoring Laboratory Tests in Recessive Dystrophic Epidermolysis Bullosa
Open Access
- 1 August 2026
- journal article
- review article
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (S2) , 62-72
Abstract
Background: Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genodermatosis characterized by skin fragility and systemic complications, including anemia, inflammation, and nutritional deficiencies. The prevalence and age of onset of monitoring laboratory tests remain poorly defined in the current literature. Objective: To characterize the frequency of nutritional deficiencies and earliest age of laboratory abnormalities in a cohort of RDEB patients. Methods: A retrospective chart review of 122 patients with RDEB seen at a tertiary care EB center (2010–2021) was conducted. Laboratory and anthropometric data from initial visits were stratified by age group and compared to institutional reference ranges. Results: Inflammatory markers were frequently elevated: C‐reactive protein (CRP) (100%, 74/74) and ESR (81%, 71/88), including in patients < 2 years. Anemia (86%, 98/114) and iron deficiency (84%, 80/95) were highly prevalent. Hypoalbuminemia was present in 69% of patients (77/112), particularly among those younger than 16 years. Thrombocytosis occurred in 41% (49/120). Anthropometric measures revealed early declines in weight‐for‐age and height‐for‐age percentiles and persistently low BMI. Mean height‐for‐age percentile decreased sharply from the 61st to the 30th %ile between ages 0–1.99 and 2–3.99 years. Vitamin D deficiency (using a 30 ng/mL cutoff) affected 49% (44/90), especially those > 8 years. Zinc and carnitine levels declined with increasing age, but the majority of patients had values within normal limits. Magnesium, selenium, phosphorus, and thyroid studies were within normal limits for most patients. Conclusions: Nutritional, hematologic, and inflammatory abnormalities are common and often present, even in infancy, among patients with RDEB. These findings underscore the need for standardized, age‐specific laboratory monitoring protocols beginning in early childhood. Early recognition of and intervention for abnormalities may improve long‐term outcomes in this medically complex population.Keywords
This publication has 28 references indexed in Scilit:
- Epidermolysis bullosa for primary care providers: A practical reviewJournal of General and Family Medicine, 2025
- Prevalence and Treatment of Vitamin K Deficiency in Paediatric Patients with Recessive Dystrophic Epidermolysis Bullosa-Severe SubtypeSkin Health and Disease, 2021
- A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and managementClinical Nutrition, 2020
- Retrospective longitudinal study of osteoporosis in adults with recessive dystrophic epidermolysis bullosaClinical Case Reports, 2018
- Modulation of inflammatory and immune responses by vitamin DJournal of Autoimmunity, 2017
- The effect of the systemic inflammatory response on plasma zinc and selenium adjusted for albuminClinical Nutrition, 2016
- Prevalence of anemia in patients with epidermolysis bullosa registered in AustraliaInternational Journal of Women's Dermatology, 2015
- Host–pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureusInternational Journal of Medical Microbiology, 2014
- Correlates of low bone mass in children with generalized forms of epidermolysis bullosaJournal of the American Academy of Dermatology, 2011
- Nutrition for Children with Epidermolysis BullosaDermatologic Clinics, 2010